Pharma ESG efforts overwhelmingly skew social, while environment and governance come up short: study

Byline: Beth Snyder Bulik Pharma companies' environmental, social and governance (ESG) efforts skew heavily toward the S, or social, a recent study found. A whopping 77% of pharma ESG efforts [...]